Latest | Instant Finance & Market News_第313页 | NewTimeSpace

10:57

[ Hang Seng TECH Index ETF (03032.HK) Rises 2.27% in Morning Trade, Turnover at HKD 137.00 Million ] NewTimeSpace News: As of 10:54 on July 8, Hang Seng TECH Index ETF (03032.HK) was up 2.27%, with the latest price at HKD 4.604.

Tag： 03032.HK ETF Hang Seng TECH Index ETF

10:53

[ CSOP FTSE East-West Equity Select ETF (03441.HK) Rises 0.84% in Morning Trade, AUM at HKD 1.485 Billion ] NewTimeSpace News: As of 10:51 on July 8, CSOP FTSE East-West Equity Select ETF (03441.HK) was up 0.84%, with the latest price at HKD 12.040.

Tag： 03441.HK CSOP FTSE East-West Equity Select ETF ETF

10:51

[ Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) Rises 0.94% in Morning Trade, Turnover at HKD 7.2760 Million ] NewTimeSpace News: As of 10:47 on July 8, Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) was up 0.94%, with the latest price at HKD 11.800.

Tag： Bosera Szse Chinext Daily (2x) Leveraged Product ETF 07234.HK

10:36

[ iShares Core Hang Seng Index ETF (03115.HK) Rises 1.83% in Morning Trade, Latest NAV at HKD 86.355 ] NewTimeSpace News: As of 10:33 on July 8, iShares Core Hang Seng Index ETF (03115.HK) was up 1.83%, with the latest price at HKD 87.740.

Tag： Ishares Core Hang Seng Index Etf ETF 03115.HK

10:29

[ SKB BIO (06990.HK) plans to issue in total 5.84 million shares by placement, with estimated net proceeds of HKD 2.72 billion ] NewTimeSpace (newtimespace.com) News, SKB BIO (06990.HK) plans to issue in total 5.84 million shares by placement, with estimated net proceeds of HKD 2.72 billion.

Tag： SKB BIO 06990.HK NewTimeSpace

10:27

[ iShares Core MSCI China Index ETF (02801.HK) Rises 1.82% in Morning Trade, AUM at HKD 13.168 Billion ] NewTimeSpace News: As of 10:25 on July 8, iShares Core MSCI China Index ETF (02801.HK) was up 1.82%, with the latest price at HKD 23.560.

Tag： iShares Core MSCI China Index ETF ETF 02801.HK

10:21

[ iShares Hang Seng TECH ETF (03067.HK) Rises 2.16% in Morning Trade, AUM at HKD 14.030 Billion ] NewTimeSpace News: As of 10:19 on July 8, iShares Hang Seng TECH ETF (03067.HK) was up 2.16%, with the latest price at HKD 9.700.

Tag： 03067.HK iShares Hang Seng TECH ETF ETF

10:13

[ Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) Rises 3.65% in Morning Trade, Turnover at HKD 9.8390 Million ] NewTimeSpace News: As of 10:09 on July 8, Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) was up 3.65%, with the latest price at HKD 8.950.

Tag： Samsung S&P Gsci Crude Oil Er Futures Etf 03175.HK ETF

10:08

[ ChinaAMC HSI ESG ETF (03403.HK) Rises 1.27% in Morning Trade, AUM at HKD 9.807 Billion ] NewTimeSpace News: As of 10:04 on July 8, ChinaAMC HSI ESG ETF (03403.HK) was up 1.27%, with the latest price at HKD 49.300.

Tag： ChinaAMC HSI ESG ETF ETF 03403.HK

10:04

[ Bosera China Reform Hong Kong Central-SOEs High Dividend Yield Index ETF (Listed Class) (03437.HK) Rises 1.91% in Morning Trade, Turnover at HKD 1.2284 Million ] NewTimeSpace News: As of 10:01 on July 8, Bosera China Reform Hong Kong Central-SOEs High Dividend Yield Index ETF (Listed Class) (03437.HK) was up 1.91%, with the latest price at HKD 9.355.

Tag： ETF Bosera China Reform Hong Kong Central-Soes High Dividend Yield Index Etf(Listed Class)03437.HK

09:59

[ Global X Hang Seng TECH ETF (02837.HK) Rises 1.71% in Morning Trade, AUM at HKD 1.930 Billion ] NewTimeSpace News: As of 09:56 on July 8, Global X Hang Seng TECH ETF (02837.HK) was up 1.71%, with the latest price at HKD 5.660.

Tag： Global X Hang Seng TECH ETF ETF 02837.HK

09:55

[ Csop Hang Seng China Enterprises Index Daily (2x) Leveraged Product (07288.HK) Rises 4.22% in Morning Trade, Turnover at HKD 3.1260 Million ] NewTimeSpace News: As of 09:51 on July 8,Csop Hang Seng China Enterprises Index Daily (2x) Leveraged Product (07288.HK) was up 4.22%, with the latest price at HKD 2.616.

Tag： 07288.HK Csop Hang Seng China Enterprises Index Daily (2x) Leveraged Product ETF

08:39

[ INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched ] NewTimeSpace News: InSilico Medicine Cayman TopCo (03696.HK) announced on 8 July that Rentosertib (ISM001-055), an AI-driven TNIK small-molecule inhibitor, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The trial plans to enrol 320 subjects across 47 clinical centres nationwide, with the primary endpoint being the annual rate of decline in forced vital capacity within 52 weeks. The asset has previously obtained FDA Orphan Drug Designation and NMPA Breakthrough Therapy Designation. The Company cautions uncertainties over business development.

Tag： Insilico 03696.HK Clinical Trial

08:34

[ ZHONG JI LS(00767.HK): Proposed Joint Establishment of RMB1 Billion Healthcare M&A Fund Focused on Longevity Science and Cell Industry ] NewTimeSpace News: Zhong Ji Longevity Science Group Limited (00767.HK) announced on 7 July that its wholly-owned subsidiary Shenzhen Zhongji Health Science Co., Limited signed a memorandum of understanding with Shenzhen Zhongtou Huijin Fund Management Co., Ltd. to jointly set up a special M&A fund for the healthcare industry with a proposed size of RMB1 billion, to be raised in three tranches. The fund will target investments in longevity science, cell therapy, anti-ageing biomedicine and premium health management industries. The memorandum is non-binding and the cooperation is subject to further formalisation.

Tag： ZHONG JI LS 00767.HK M&A Fund

08:25

[ CHERY AUTO(09973.HK): Signed Auto Sales Framework Agreement with Guangdong Ruixun; Aggregate Annual Caps Totalling RMB1.55 Billion for 2026–2028 ] NewTimeSpace News: Chery Automobile Co., Ltd. (09973.HK) announced on 7 July that it entered into an automobile sales framework agreement with Guangdong Ruixun Automobile Sales Service Co., Ltd. The annual caps are RMB250 million for 2026, RMB500 million for 2027 and RMB800 million for 2028, aggregating RMB1.55 billion. Controlled by Ms. Wang Laichun, the Company’s Non-executive Director, Guangdong Ruixun gives rise to continuing connected transactions. Pricing terms will not be more favourable than those offered to independent third parties. The Group intends to expand domestic market coverage via Ruixun’s sales network.

Tag： CHERY AUTO 09973.HK Sales Agreement

08:19

[ LANCANG TEA(06911.HK): Independent Investigation Confirms Three Incidents Stemmed from Personal Misconduct of Former Senior Executives; Remedial Measures Implemented ] NewTimeSpace News: Pu'Er Lancang Ancient Tea Co., Ltd. (06911.HK) announced on 7 July that an independent investigation report confirmed three matters – private lending disputes, bank account freezing and litigation, as well as warehouse inventory shortages – arose from personal irregular conduct of former senior executives Ms. Wang, ex-General Manager, and Mr. Zhang, ex-Director. Relevant involved parties are not connected with the Company. The two executives shall be held accountable for relevant losses, and internal control rectifications have been completed. No other irregularities or undisclosed material matters were identified as of the report date.

Tag： LANCANG TEA 06911.HK independent investigation

08:11

[ DKE Holding Company Limited (01770.HK): Delay to H-Share Listing Timetable; Trading Expected to Commence on 9 July ] NewTimeSpace News: DKE Holding Company Limited (01770.HK) announced on 7 July that the timetable for its H-share listing has been delayed, as additional time is required to finalise the final offer price announcement and obtain regulatory approvals. Trading of the H-shares is expected to commence on Thursday, 9 July 2026. The Company published its Prospectus on 29 June previously.

Tag： DKE IPO 01770.HK IPO Listing Delay

08:06

[ JENSCARE-B(09877.HK): LuX-Valve Plus Transcatheter Tricuspid Valve Replacement System Secures EU MDR CE Certification ] NewTimeSpace News: Jenscare Scientific Co., Ltd. (09877.HK) announced on 8 July that its self-developed LuX-Valve Plus transcatheter tricuspid valve replacement system has obtained EU MDR CE certification, making it the world’s second approved in-situ transcatheter tricuspid valve replacement product. Over 1,000 clinical implantations have been completed across dozens of countries and regions on five continents globally. The device has received FDA Breakthrough Device designation and entered NMPA’s Special Review Procedure for Innovative Medical Devices. The Company cautions that there is no guarantee of successful product launch and commercialisation.

Tag： JENSCARE-B 09877.HK MDR CE certification

07:59

[ CHIHO ENV(00976.HK): Initiates Legal Proceedings Over Appointment of Receivers to Subsidiary Shares, Seeking Declaration That Appointments Are Null and Void ] NewTimeSpace News: Chiho Environmental Group Limited (00976.HK) announced on 7 July that it has commenced legal proceedings in the High Court of Hong Kong, seeking a declaration that the appointments of receivers over its subsidiary shares are null and void and an injunction restraining the receivers from taking any actions. The Group has held the view that the receivership appointments were invalid, yet the receivers proceeded to enter into a sale agreement for the Scholz Group. The Company’s shares have been suspended from trading since 1 April 2025 and will remain suspended until further notice.

Tag： CHIHO ENV 00976.HK Litigation

07:51

[ SINO BIOPHARM(01177.HK): Exclusive Licensing Agreement with AstraZeneca for TQC3721, USD200 Million Upfront Payment plus Up to USD1.9 Billion Milestones ] NewTimeSpace News: Sino Biopharmaceutical Limited (01177.HK) announced that its subsidiary Chia Tai Tianqing entered into an exclusive licensing agreement with AstraZeneca for TQC3721, an in-house developed PDE3/4 inhibitor. The Group will receive an upfront payment of USD200 million, aggregate development, regulatory and sales milestone payments of up to USD1.9 billion, plus tiered royalties at rates up to double digits based on annual net sales.

Tag： SINO BIOPHARM 01177.HK AstraZeneca cooperation

Scan QR Code

Download App